Global EGFR Mutation Test Market Growth (Status and Outlook) 2024-2030

November 2024 | 106 pages | ID: G8D12818B7D0EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global EGFR Mutation Test market size was valued at US$ million in 2023. With growing demand in downstream market, the EGFR Mutation Test is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global EGFR Mutation Test market. EGFR Mutation Test are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of EGFR Mutation Test. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the EGFR Mutation Test market.

Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is generally observed in NSCLCs, especially in adenocarcinoma tumors. According to the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society, there are around 50% of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are related to micro papillary predominant subtype and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients with NSCLC. Targeted therapy involving tyrosine kinase inhibitors such as gefitinib and erotinib is used in the treatment of patients with NSCLC. EGFR biomarker detects the presence of specific alterations in EGFR gene, which may lead to the development of tumor.

Increasing global prevalence of lung cancer is expected to fuel growth of the global EGFR mutation test market over the forecast period. Increasing adoption of biomarker therapy is also expected to boost growth of the market worldwide over the forecast period.

Key Features:

The report on EGFR Mutation Test market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the EGFR Mutation Test market. It may include historical data, market segmentation by Type (e.g., DNA Sequencing, Kits), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the EGFR Mutation Test market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the EGFR Mutation Test market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the EGFR Mutation Test industry. This include advancements in EGFR Mutation Test technology, EGFR Mutation Test new entrants, EGFR Mutation Test new investment, and other innovations that are shaping the future of EGFR Mutation Test.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the EGFR Mutation Test market. It includes factors influencing customer ' purchasing decisions, preferences for EGFR Mutation Test product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the EGFR Mutation Test market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting EGFR Mutation Test market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the EGFR Mutation Test market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the EGFR Mutation Test industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the EGFR Mutation Test market.

Market Segmentation:

EGFR Mutation Test market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • DNA Sequencing
  • Kits
Segmentation by application
  • Cancer Hospitals
  • Clinical Research Institutes
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Abbott
  • Merck
  • Thermo Fisher Scientific
  • Illumina
  • BioMerieux
  • QIAGEN
  • Agilent Technologies
  • Hologic
  • Novartis
  • Roche
  • Genomic Health
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global EGFR Mutation Test Market Size 2019-2030
  2.1.2 EGFR Mutation Test Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 EGFR Mutation Test Segment by Type
  2.2.1 DNA Sequencing
  2.2.2 Kits
2.3 EGFR Mutation Test Market Size by Type
  2.3.1 EGFR Mutation Test Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global EGFR Mutation Test Market Size Market Share by Type (2019-2024)
2.4 EGFR Mutation Test Segment by Application
  2.4.1 Cancer Hospitals
  2.4.2 Clinical Research Institutes
2.5 EGFR Mutation Test Market Size by Application
  2.5.1 EGFR Mutation Test Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global EGFR Mutation Test Market Size Market Share by Application (2019-2024)

3 EGFR MUTATION TEST MARKET SIZE BY PLAYER

3.1 EGFR Mutation Test Market Size Market Share by Players
  3.1.1 Global EGFR Mutation Test Revenue by Players (2019-2024)
  3.1.2 Global EGFR Mutation Test Revenue Market Share by Players (2019-2024)
3.2 Global EGFR Mutation Test Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 EGFR MUTATION TEST BY REGIONS

4.1 EGFR Mutation Test Market Size by Regions (2019-2024)
4.2 Americas EGFR Mutation Test Market Size Growth (2019-2024)
4.3 APAC EGFR Mutation Test Market Size Growth (2019-2024)
4.4 Europe EGFR Mutation Test Market Size Growth (2019-2024)
4.5 Middle East & Africa EGFR Mutation Test Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas EGFR Mutation Test Market Size by Country (2019-2024)
5.2 Americas EGFR Mutation Test Market Size by Type (2019-2024)
5.3 Americas EGFR Mutation Test Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC EGFR Mutation Test Market Size by Region (2019-2024)
6.2 APAC EGFR Mutation Test Market Size by Type (2019-2024)
6.3 APAC EGFR Mutation Test Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe EGFR Mutation Test by Country (2019-2024)
7.2 Europe EGFR Mutation Test Market Size by Type (2019-2024)
7.3 Europe EGFR Mutation Test Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa EGFR Mutation Test by Region (2019-2024)
8.2 Middle East & Africa EGFR Mutation Test Market Size by Type (2019-2024)
8.3 Middle East & Africa EGFR Mutation Test Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL EGFR MUTATION TEST MARKET FORECAST

10.1 Global EGFR Mutation Test Forecast by Regions (2025-2030)
  10.1.1 Global EGFR Mutation Test Forecast by Regions (2025-2030)
  10.1.2 Americas EGFR Mutation Test Forecast
  10.1.3 APAC EGFR Mutation Test Forecast
  10.1.4 Europe EGFR Mutation Test Forecast
  10.1.5 Middle East & Africa EGFR Mutation Test Forecast
10.2 Americas EGFR Mutation Test Forecast by Country (2025-2030)
  10.2.1 United States EGFR Mutation Test Market Forecast
  10.2.2 Canada EGFR Mutation Test Market Forecast
  10.2.3 Mexico EGFR Mutation Test Market Forecast
  10.2.4 Brazil EGFR Mutation Test Market Forecast
10.3 APAC EGFR Mutation Test Forecast by Region (2025-2030)
  10.3.1 China EGFR Mutation Test Market Forecast
  10.3.2 Japan EGFR Mutation Test Market Forecast
  10.3.3 Korea EGFR Mutation Test Market Forecast
  10.3.4 Southeast Asia EGFR Mutation Test Market Forecast
  10.3.5 India EGFR Mutation Test Market Forecast
  10.3.6 Australia EGFR Mutation Test Market Forecast
10.4 Europe EGFR Mutation Test Forecast by Country (2025-2030)
  10.4.1 Germany EGFR Mutation Test Market Forecast
  10.4.2 France EGFR Mutation Test Market Forecast
  10.4.3 UK EGFR Mutation Test Market Forecast
  10.4.4 Italy EGFR Mutation Test Market Forecast
  10.4.5 Russia EGFR Mutation Test Market Forecast
10.5 Middle East & Africa EGFR Mutation Test Forecast by Region (2025-2030)
  10.5.1 Egypt EGFR Mutation Test Market Forecast
  10.5.2 South Africa EGFR Mutation Test Market Forecast
  10.5.3 Israel EGFR Mutation Test Market Forecast
  10.5.4 Turkey EGFR Mutation Test Market Forecast
  10.5.5 GCC Countries EGFR Mutation Test Market Forecast
10.6 Global EGFR Mutation Test Forecast by Type (2025-2030)
10.7 Global EGFR Mutation Test Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Abbott
  11.1.1 Abbott Company Information
  11.1.2 Abbott EGFR Mutation Test Product Offered
  11.1.3 Abbott EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Abbott Main Business Overview
  11.1.5 Abbott Latest Developments
11.2 Merck
  11.2.1 Merck Company Information
  11.2.2 Merck EGFR Mutation Test Product Offered
  11.2.3 Merck EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Merck Main Business Overview
  11.2.5 Merck Latest Developments
11.3 Thermo Fisher Scientific
  11.3.1 Thermo Fisher Scientific Company Information
  11.3.2 Thermo Fisher Scientific EGFR Mutation Test Product Offered
  11.3.3 Thermo Fisher Scientific EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Thermo Fisher Scientific Main Business Overview
  11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Illumina
  11.4.1 Illumina Company Information
  11.4.2 Illumina EGFR Mutation Test Product Offered
  11.4.3 Illumina EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Illumina Main Business Overview
  11.4.5 Illumina Latest Developments
11.5 BioMerieux
  11.5.1 BioMerieux Company Information
  11.5.2 BioMerieux EGFR Mutation Test Product Offered
  11.5.3 BioMerieux EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 BioMerieux Main Business Overview
  11.5.5 BioMerieux Latest Developments
11.6 QIAGEN
  11.6.1 QIAGEN Company Information
  11.6.2 QIAGEN EGFR Mutation Test Product Offered
  11.6.3 QIAGEN EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 QIAGEN Main Business Overview
  11.6.5 QIAGEN Latest Developments
11.7 Agilent Technologies
  11.7.1 Agilent Technologies Company Information
  11.7.2 Agilent Technologies EGFR Mutation Test Product Offered
  11.7.3 Agilent Technologies EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Agilent Technologies Main Business Overview
  11.7.5 Agilent Technologies Latest Developments
11.8 Hologic
  11.8.1 Hologic Company Information
  11.8.2 Hologic EGFR Mutation Test Product Offered
  11.8.3 Hologic EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Hologic Main Business Overview
  11.8.5 Hologic Latest Developments
11.9 Novartis
  11.9.1 Novartis Company Information
  11.9.2 Novartis EGFR Mutation Test Product Offered
  11.9.3 Novartis EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Novartis Main Business Overview
  11.9.5 Novartis Latest Developments
11.10 Roche
  11.10.1 Roche Company Information
  11.10.2 Roche EGFR Mutation Test Product Offered
  11.10.3 Roche EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Roche Main Business Overview
  11.10.5 Roche Latest Developments
11.11 Genomic Health
  11.11.1 Genomic Health Company Information
  11.11.2 Genomic Health EGFR Mutation Test Product Offered
  11.11.3 Genomic Health EGFR Mutation Test Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Genomic Health Main Business Overview
  11.11.5 Genomic Health Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES Table 1. EGFR Mutation Test Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of DNA Sequencing
Table 3. Major Players of Kits
Table 4. EGFR Mutation Test Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global EGFR Mutation Test Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global EGFR Mutation Test Market Size Market Share by Type (2019-2024)
Table 7. EGFR Mutation Test Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global EGFR Mutation Test Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global EGFR Mutation Test Market Size Market Share by Application (2019-2024)
Table 10. Global EGFR Mutation Test Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global EGFR Mutation Test Revenue Market Share by Player (2019-2024)
Table 12. EGFR Mutation Test Key Players Head office and Products Offered
Table 13. EGFR Mutation Test Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global EGFR Mutation Test Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global EGFR Mutation Test Market Size Market Share by Regions (2019-2024)
Table 18. Global EGFR Mutation Test Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global EGFR Mutation Test Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas EGFR Mutation Test Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas EGFR Mutation Test Market Size Market Share by Country (2019-2024)
Table 22. Americas EGFR Mutation Test Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas EGFR Mutation Test Market Size Market Share by Type (2019-2024)
Table 24. Americas EGFR Mutation Test Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas EGFR Mutation Test Market Size Market Share by Application (2019-2024)
Table 26. APAC EGFR Mutation Test Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC EGFR Mutation Test Market Size Market Share by Region (2019-2024)
Table 28. APAC EGFR Mutation Test Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC EGFR Mutation Test Market Size Market Share by Type (2019-2024)
Table 30. APAC EGFR Mutation Test Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC EGFR Mutation Test Market Size Market Share by Application (2019-2024)
Table 32. Europe EGFR Mutation Test Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe EGFR Mutation Test Market Size Market Share by Country (2019-2024)
Table 34. Europe EGFR Mutation Test Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe EGFR Mutation Test Market Size Market Share by Type (2019-2024)
Table 36. Europe EGFR Mutation Test Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe EGFR Mutation Test Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa EGFR Mutation Test Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa EGFR Mutation Test Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa EGFR Mutation Test Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa EGFR Mutation Test Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa EGFR Mutation Test Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa EGFR Mutation Test Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of EGFR Mutation Test
Table 45. Key Market Challenges & Risks of EGFR Mutation Test
Table 46. Key Industry Trends of EGFR Mutation Test
Table 47. Global EGFR Mutation Test Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global EGFR Mutation Test Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global EGFR Mutation Test Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global EGFR Mutation Test Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Abbott Details, Company Type, EGFR Mutation Test Area Served and Its Competitors
Table 52. Abbott EGFR Mutation Test Product Offered
Table 53. Abbott EGFR Mutation Test Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Abbott Main Business
Table 55. Abbott Latest Developments
Table 56. Merck Details, Company Type, EGFR Mutation Test Area Served and Its Competitors
Table 57. Merck EGFR Mutation Test Product Offered
Table 58. Merck Main Business
Table 59. Merck EGFR Mutation Test Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Merck Latest Developments
Table 61. Thermo Fisher Scientific Details, Company Type, EGFR Mutation Test Area Served and Its Competitors
Table 62. Thermo Fisher Scientific EGFR Mutation Test Product Offered
Table 63. Thermo Fisher Scientific Main Business
Table 64. Thermo Fisher Scientific EGFR Mutation Test Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Thermo Fisher Scientific Latest Developments
Table 66. Illumina Details, Company Type, EGFR Mutation Test Area Served and Its Competitors
Table 67. Illumina EGFR Mutation Test Product Offered
Table 68. Illumina Main Business
Table 69. Illumina EGFR Mutation Test Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Illumina Latest Developments
Table 71. BioMerieux Details, Company Type, EGFR Mutation Test Area Served and Its Competitors
Table 72. BioMerieux EGFR Mutation Test Product Offered
Table 73. BioMerieux Main Business
Table 74. BioMerieux EGFR Mutation Test Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. BioMerieux Latest Developments
Table 76. QIAGEN Details, Company Type, EGFR Mutation Test Area Served and Its Competitors
Table 77. QIAGEN EGFR Mutation Test Product Offered
Table 78. QIAGEN Main Business
Table 79. QIAGEN EGFR Mutation Test Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. QIAGEN Latest Developments
Table 81. Agilent Technologies Details, Company Type, EGFR Mutation Test Area Served and Its Competitors
Table 82. Agilent Technologies EGFR Mutation Test Product Offered
Table 83. Agilent Technologies Main Business
Table 84. Agilent Technologies EGFR Mutation Test Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Agilent Technologies Latest Developments
Table 86. Hologic Details, Company Type, EGFR Mutation Test Area Served and Its Competitors
Table 87. Hologic EGFR Mutation Test Product Offered
Table 88. Hologic Main Business
Table 89. Hologic EGFR Mutation Test Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Hologic Latest Developments
Table 91. Novartis Details, Company Type, EGFR Mutation Test Area Served and Its Competitors
Table 92. Novartis EGFR Mutation Test Product Offered
Table 93. Novartis Main Business
Table 94. Novartis EGFR Mutation Test Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Novartis Latest Developments
Table 96. Roche Details, Company Type, EGFR Mutation Test Area Served and Its Competitors
Table 97. Roche EGFR Mutation Test Product Offered
Table 98. Roche Main Business
Table 99. Roche EGFR Mutation Test Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Roche Latest Developments
Table 101. Genomic Health Details, Company Type, EGFR Mutation Test Area Served and Its Competitors
Table 102. Genomic Health EGFR Mutation Test Product Offered
Table 103. Genomic Health EGFR Mutation Test Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Genomic Health Main Business
Table 105. Genomic Health Latest Developments

LIST OF FIGURES Figure 1. EGFR Mutation Test Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global EGFR Mutation Test Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. EGFR Mutation Test Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. EGFR Mutation Test Sales Market Share by Country/Region (2023)
Figure 8. EGFR Mutation Test Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global EGFR Mutation Test Market Size Market Share by Type in 2023
Figure 10. EGFR Mutation Test in Cancer Hospitals
Figure 11. Global EGFR Mutation Test Market: Cancer Hospitals (2019-2024) & ($ Millions)
Figure 12. EGFR Mutation Test in Clinical Research Institutes
Figure 13. Global EGFR Mutation Test Market: Clinical Research Institutes (2019-2024) & ($ Millions)
Figure 14. Global EGFR Mutation Test Market Size Market Share by Application in 2023
Figure 15. Global EGFR Mutation Test Revenue Market Share by Player in 2023
Figure 16. Global EGFR Mutation Test Market Size Market Share by Regions (2019-2024)
Figure 17. Americas EGFR Mutation Test Market Size 2019-2024 ($ Millions)
Figure 18. APAC EGFR Mutation Test Market Size 2019-2024 ($ Millions)
Figure 19. Europe EGFR Mutation Test Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa EGFR Mutation Test Market Size 2019-2024 ($ Millions)
Figure 21. Americas EGFR Mutation Test Value Market Share by Country in 2023
Figure 22. United States EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC EGFR Mutation Test Market Size Market Share by Region in 2023
Figure 27. APAC EGFR Mutation Test Market Size Market Share by Type in 2023
Figure 28. APAC EGFR Mutation Test Market Size Market Share by Application in 2023
Figure 29. China EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 33. India EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe EGFR Mutation Test Market Size Market Share by Country in 2023
Figure 36. Europe EGFR Mutation Test Market Size Market Share by Type (2019-2024)
Figure 37. Europe EGFR Mutation Test Market Size Market Share by Application (2019-2024)
Figure 38. Germany EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 39. France EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa EGFR Mutation Test Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa EGFR Mutation Test Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa EGFR Mutation Test Market Size Market Share by Application (2019-2024)
Figure 46. Egypt EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country EGFR Mutation Test Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 52. APAC EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 53. Europe EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 55. United States EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 56. Canada EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 57. Mexico EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 58. Brazil EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 59. China EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 60. Japan EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 61. Korea EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 63. India EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 64. Australia EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 65. Germany EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 66. France EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 67. UK EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 68. Italy EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 69. Russia EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 70. Spain EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 71. Egypt EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 72. South Africa EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 73. Israel EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 74. Turkey EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries EGFR Mutation Test Market Size 2025-2030 ($ Millions)
Figure 76. Global EGFR Mutation Test Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global EGFR Mutation Test Market Size Market Share Forecast by Application (2025-2030)